SB1518 for Patients With Myelodysplastic Syndrome (MDS)

NCT01436084 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Colloborating sponsor decision.

Conditions

Leukemia

Interventions

DRUG: SB1518

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]